Increasing the Dose Intensity of Chemotherapy by Means of Granulocyte-colony Stimulating Factor (G-CSF) Support in the Treatment of Small Cell Lung Cancer (SCLC)

By Girling D.J.   Thatcher N.   Clark P.I.   Stephens R.J.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1263-1263

Elsevier

Access to resources Recommend Favorite

A Randomised Study Comparing Granulocyte-colony Stimulating Factor (G-CSF) with G-CSF Plus Thymostimulin in the Treatment of Haematological Toxicity in Patients with Advanced Breast Cancer after High Dose Mitoxantrone Therapy

By Sanchiz F.   Milla A.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 52-56

Elsevier

Access to resources Recommend Favorite

Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy

By Yakushijin Yoshihiro   Shikata Hisaharu   Takaoka Ikue   Horikawa Tamami   Takeuchi Kazuhito   Yamanouchi Jun   Azuma Taichi   Narumi Hiroshi   Hato Takaaki   Yasukawa Masaki  

International Journal of Clinical Oncology, Vol. 16, Iss. 2, 2011-04 ,pp. : 118-124

Springer Publishing Company

Access to resources Recommend Favorite

The Feasibility of Using Glycosylated Recombinant Human Granulocyte Colony-stimulating Factor (G-CSF) to Increase the Planned Dose Intensity of Doxorubicin, Cyclophosphamide and Etoposide (ACE) in the Treatment of Small Cell Lung Cancer

By Thatcher N.   Anderson H.   Bleehen N.M.   Girling D.J.   Lallemand G.   Machin D.   Stephens R.J.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 152-156

Elsevier

Access to resources Recommend Favorite

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia

By Lalami Y.   Paesmans M.  

Supportive Care in Cancer, Vol. 12, Iss. 10, 2004-10 ,pp. : 725-730

Springer Publishing Company

Access to resources Recommend Favorite